An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial

An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial

Abstract Objectives We will investigate the effectiveness of high dose Interferon Beta 1a, compared to low dose Interferon Beta 1a (the base therapeutic regimen) in COVID-19 Confirmed Cases (Either RT-PCR or CT Scan Confirmed) with moderate to severe disease Trial Design This is a single center, ope...

Full description

Bibliographic Details
Main Authors: Ilad Alavi Darazam, Firouze Hatami, Mohammad Mahdi Rabiei, Mohamad Amin Pourhoseingholi, Omid Moradi, Shervin Shokouhi, Mohammad Reza Hajesmaeili, Minoosh Shabani, Seyed Sina Naghibi Irvani
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Trials
Subjects:
COVID-19
SARS-COV-2
Randomized controlled trial
lopinavir/ritonavir
Interferon-β 1a
Online Access:http://link.springer.com/article/10.1186/s13063-020-04812-2

Internet

http://link.springer.com/article/10.1186/s13063-020-04812-2

Similar Items